Immunotherapy enhances your immune system’s ability to target cancer cells. Chemotherapy acts directly on cancer cells to keep them from replicating. Immunotherapy and chemotherapy are two ...

Chemotherapy for lung cancer is used for different purposes depending on the type and stage of cancer you have. This includes achieving cancer remission, shrinking a tumor before surgery, killing ...

The effects of chemotherapy can continue after treatment or even develop years later. These include effects on the brain, heart, bones, nervous system, lungs, and other systems. Chemotherapy is ...

Although chemotherapy is an effective cancer treatment, it's not recommended for everyone. While most individuals with cancer are offered chemotherapy as part of their treatment plan, there are times ...

Cancer treatment is a grueling process, and chemotherapy often comes with a host of side effects that extend far beyond physical discomfort. One of the most troubling yet frequently overlooked ...

Long before R.F.K., Jr., promised to “Make America Healthy Again,” wellness influencers were peddling a seductive promise of ...

The following is a summary of “Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer,” published in the January 2025 issue of Critical Care by Hoeppner et al. Researchers ...

Doctors have used chemotherapy (chemo) to treat cancer since the 1940s. The advantage of these drugs is they kill cancer cells throughout your body. One downside is the side effects they can ...

"When you see these other people when they’re having their chemotherapy, they were doing it as a group, with a support mechanism." The Princess of Wales, 43, contrasted her own experience while ...

Get Instant Summarized Text (Gist) A clinical trial demonstrated that combining chemotherapy with immunotherapy significantly improves treatment outcomes for diffuse large B-cell lymphoma (DLBCL ...

An important question is whether perioperative chemotherapy is preferable to preoperative chemoradiotherapy. In this phase 3, multicenter, randomized trial, we assigned in a 1:1 ratio patients ...